Evidence map›Paper›PMID 42244233›Full record

Trial reportJournal of the International AIDS Society2026

Qualitative Insights on Client and Provider Barriers and Facilitators to Using a Novel Online HIV Pre- and Post-Exposure Delivery Model in Kenya.

Phelix Okello, Nicholas Thuo, Stephanie D Roche, Arden L Saravis, Daniel Mwai, Paulami Naik, Catherine Kiptinness, Tabitha Kareithi, Melissa L Mugambi, Monisha Sharma and 2 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05377138 (Evaluate and Optimize a Virtual Care Model for PrEP Delivery), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05377138 nacompletednot on this map

Evaluate and Optimize a Virtual Care Model for PrEP Delivery: Pilot Study

TypeinterventionalSponsorUniversity of WashingtonRan2022 to 2023Enrolled2,357ConditionsHIV InfectionsArmsOnline PEP/PrEP delivery
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Phelix OkelloPartners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Nicholas ThuoPartners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Stephanie D RochePublic Health Science Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Arden L SaravisDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Daniel MwaiPartners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Paulami NaikDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Catherine KiptinnessPartners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Tabitha KareithiPartners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Melissa L MugambiDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Monisha SharmaDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-7599-1561
Kenneth NgureDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Katrina F OrtbaldPublic Health Science Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-5675-8836

Funding

Gates Foundation INV-037646
6 · The paper itself

Abstract

introductionOnline delivery of HIV pre- and post-exposure prophylaxis (PrEP and PEP) could address persistent access barriers, yet implementation across Africa remains limited. The ePrEP Kenya Pilot (NCT05377138) integrated PrEP and PEP services into an existing e-pharmacy platform and identified client- and provider-level barriers and facilitators to use.

methodsIn the pilot, clinicians screened adults (age 18+) in Nairobi and Mombasa Counties for PrEP and PEP eligibility via telehealth; pharmaceutical technologists courier-delivered HIV testing services (including self-testing) and dispensed PrEP or PEP to eligible clients who paid 150-250 KES (∼$1-2 USD) for HIV testing, ≤149 KES (∼$1 USD) for courier delivery and nothing for telehealth consultation or PrEP/PEP drugs. We conducted monthly check-in calls with providers and, near study endline, in-depth interviews (IDIs) with purposively sampled clients and all providers. We analysed verbatim call transcripts and IDIs inductively, then mapped identified barriers and facilitators to the Consolidated Framework for Implementation Research (CFIR).

resultsFrom February to November 2023, we conducted 10 check-in calls and interviewed 30 clients (10 PEP, 10 PrEP with 1+ refill, 10 PrEP with no refills) and 10 providers (4 clinicians, 6 pharm techs). Clients had a median age of 27 years (IQR 25-30) and providers 28 years (IQR 27-31); 53% (16/30) of clients and 30% (3/10) of providers were female. In the Outer Setting CFIR domain, providers identified motorcycle manoeuvrability as a delivery facilitator but noted that traffic, poor road infrastructure, bad weather and personal safety concerns posed challenges. In the Inner Setting domain, providers identified information-sharing practices and collegiality as facilitators. In the Individuals domain, clients' capability, opportunity and motivation to use online PrEP/PEP services was reportedly facilitated by app-guided HIV self-testing, broad delivery zones and enhanced privacy, but hindered by low awareness of these services, limited access to internet-enabled devices, data security concerns and uncertainties around couriers' pharmacy credentials. Recommendations included reducing client costs, expanding delivery coverage and hours, and offering alternative delivery options (e.g. medication pick-up lockers).

conclusionsOnline PrEP and PEP delivery is a promising differentiated service model, especially if partially subsidized by third-party payers. Implementation success will require model adaptations that address logistical, infrastructural and awareness barriers.

Indexed as

Anti-HIV AgentsHealth Services AccessibilityHIV InfectionsPost-Exposure ProphylaxisPre-Exposure ProphylaxisAdolescentAdultFemaleHealth PersonnelHumansKenyaMaleMiddle AgedPilot ProjectsTelemedicineYoung AdultAnti-HIV Agentsbarriers and facilitatorsHIVKenyaonline PrEP and PEP deliverypost‐exposure prophylaxispre‐exposure prophylaxis

Identifiers

PMID42244233
PMCPMC13238538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.